Table 1.
Demographics and baseline characteristics.
| Characteristics | Iopromide 370 | Iomeprol 400 | Comparison, P value |
|---|---|---|---|
| No. of patients | 151 | 146 | |
| No. male (%) | 87 (58%) | 88 (60%) | 0.64† |
| Age (years)* | 55 ± 9 (22–75) | 52 ± 11(22–75) | 0.07‡ |
| Height (cm)* | 164 ± 8(145–188) | 166 ± 8(148–184) | 0.26‡ |
| BMI (kg/m2)* | 24.6 ± 3.0 (18.4–37.0) | 24.8 ± 2.7 (15.8–32.3) | 0.35‡ |
| Heart rate (beats per minute)* | 70 ± 11(50–106) | 71 ± 11(42–102) | 0.24‡ |
| Hypertension | 44 (29%) | 45 (31%) | 0.75 |
| Diabetes | 12 (8%) | 17 (12%) | 0.28 |
| Smoking | 25 (17%) | 36 (25%) | 0.08 |
| Exertional chest pain | 22 (15%) | 16(11%) | 0.35 |
| Stable chest pain | 35 (23%) | 36 (25%) | 0.77 |
| Atypical chest pain | 26 (17%) | 13 (9%) | 0.03 |
| Hyperlipidemia | 22 (15%) | 19 (13%) | 0.70 |
| Use of metoprolol | 87 (58%) | 96 (66%) | 0.15 |
| Use of nitroglycerin | 116(77%) | 104 (71%) | 0.27 |
*
Data are mean values with standard deviations, and numbers in parentheses are ranges.
†
Two-group chi-squared test (two-sided).
‡
Two-group Wilcoxon rank sum test (two-sided).